Interim CEO departs, CFO takes PEO role, new CCO, FDA immunobridging path

Invivyd, Inc.

Jeremy Gowler ceases as interim CEO, COO, CCO effective May 30; employment ends June 29.
CFO William Duke Jr. appointed principal executive officer; continues as CFO and principal accounting officer.
Timothy Lee appointed Chief Commercial Officer; previously led Amylyx sales ($390M revenue in 14 months).
FDA alignment on repeatable immunobridging pathway for serial mAbs COVID-19 EUAs; Est. clinical cost $25-40M per mAb.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

William Duke, Jr.

Principal Executive Officer

IVVD · Invivyd, Inc.

Effective: 2024-05-30
Filed: May 31, 2024, 7:59 PM ET

Effective May 30, 2024, William Duke, Jr., the Company’s Chief Financial Officer, will serve as the Company’s “principal executive officer”.

Departed (interim)

Jeremy Gowler

Interim Chief Executive Officer, Chief Operating Officer and Chief Commercial Officer

IVVD · Invivyd, Inc.

Effective: 2024-05-30
Filed: May 31, 2024, 7:59 PM ET

Jeremy Gowler, the Interim Chief Executive Officer, Chief Operating Officer and Chief Commercial Officer of Invivyd, Inc. (the “Company”), ceased serving as an executive officer and as the Company’s “principal executive officer,” effective as of May 30, 2024, with his employment terminating on June 29, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

William Duke, Jr. was appointed as Principal Executive Officer at Invivyd, Inc..

Action: appointed
Role: Principal Executive Officer

Exact text from the filing

Effective May 30, 2024, William Duke, Jr., the Company’s Chief Financial Officer, will serve as the Company’s “principal executive officer”.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeremy Gowler departed as Interim Chief Executive Officer, Chief Operating Officer and Chief Commercial Officer at Invivyd, Inc..

Action: ceased serving
Role: Interim Chief Executive Officer, Chief Operating Officer and Chief Commercial Officer

Exact text from the filing

Jeremy Gowler, the Interim Chief Executive Officer, Chief Operating Officer and Chief Commercial Officer of Invivyd, Inc. (the “Company”), ceased serving as an executive officer and as the Company’s “principal executive officer,” effective as of May 30, 2024, with his employment terminating on June 29, 2024.

View on SEC.gov

Invivyd, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-151007

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.